MedTrace Logo

Efficacy of Intralesional Triamcinolone Injection in the Treatment of Vitiligo

NCT03365141 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2017-12-07

No results posted yet for this study

Summary

A randomized split-body pilot study was planned to confirm efficacy of intralesiona triamcinolone injection in patients with vitiligo

Conditions

  • Vitiligo
  • Treatment
  • Intralesional Injection
  • Corticosteroid

Interventions

DRUG

Triamcinolone acetonide 0.4mg/cc

* Intralesional injection of dilute triamcinolone acetonide with 2% lidocaine (400mg/20 mL) would be performed to reduce pain when injecting the drug. * Once weekly, for a total of 12 weeks

DEVICE

Phototherapy (NBUVB or excimer laser)

NBUVB or excimer laser treatment weekly

DRUG

Topical tacrolimus

Application of topical tacrolimus ointment twice a day

Sponsors & Collaborators

  • The Catholic University of Korea

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-11-14
Primary Completion
2018-09-15
Completion
2018-09-15

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03365141 on ClinicalTrials.gov